IL-1α is Critical for Resistance Against Highly Virulent Isolates.

TitleIL-1α is Critical for Resistance Against Highly Virulent Isolates.
Publication TypeJournal Article
Year of Publication2017
AuthorsCaffrey-Carr AK, Kowalski CH, Beattie SR, Blaseg NA, Upshaw CR, Thammahong A, Lust HE, Tang Y-W, Hohl TM, Cramer RA, Obar JJ
JournalInfect Immun
Date Published2017 Sep 25
ISSN1098-5522
Abstract

Heterogeneity amongst isolates results in unique virulence potential and inflammatory responses. How these isolates drive specific immune responses and how this affects fungal-induced lung damage and disease outcome is unresolved. We demonstrate that the highly virulent CEA10 strain is able to rapidly germinate within the immune competent lung environment inducing greater lung damage, vascular leakage, and IL-1α release compared to the low virulent Af293 strain that germinates with lower frequency in this environment. Importantly, clearance of CEA10 was consequently dependent on IL-1α in contrast to Af293. Release of IL-1α occurred in a caspase 1/11- and P2XR7-independent mechanism, but was dependent on calpain activity. Our finding that early fungal conidia germination drives greater lung damage and IL-1α dependent inflammation is supported by three independent experimental lines. First, pre-germination of Af293 prior to challenge drives lung damage and an IL-1α dependent neutrophil response. Second, the virulent EVOL20 strain, derived from Af293, is able to germinate in the airways, leading to enhanced lung damage and IL-1α dependent inflammation and fungal clearance. Third, primary environmental isolates that rapidly germinate in the airway conditions follow the same trend toward IL-1α dependency. Our data support the hypothesis that phenotypic variation significantly contributes to disease outcomes.

DOI10.1128/IAI.00661-17
Alternate JournalInfect. Immun.
PubMed ID28947643
PubMed Central IDPMC5695118
Grant ListP30 CA008748 / CA / NCI NIH HHS / United States
R01 AI093808 / AI / NIAID NIH HHS / United States
R25 GM086262 / GM / NIGMS NIH HHS / United States

Person Type: